Page last updated: 2024-10-15

phosphoserine and Pseudohypoaldosteronism

phosphoserine has been researched along with Pseudohypoaldosteronism in 1 studies

Phosphoserine: The phosphoric acid ester of serine.

Pseudohypoaldosteronism: A heterogeneous group of disorders characterized by renal electrolyte transport dysfunctions. Congenital forms are rare autosomal disorders characterized by neonatal hypertension, HYPERKALEMIA, increased RENIN activity and ALDOSTERONE concentration. The Type I features HYPERKALEMIA with sodium wasting; Type II, HYPERKALEMIA without sodium wasting. Pseudohypoaldosteronism can be the result of a defective renal electrolyte transport protein or acquired after KIDNEY TRANSPLANTATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CastaƱeda-Bueno, M1
Arroyo, JP1
Zhang, J1
Puthumana, J1
Yarborough, O1
Shibata, S1
Rojas-Vega, L1
Gamba, G1
Rinehart, J1
Lifton, RP1

Other Studies

1 other study available for phosphoserine and Pseudohypoaldosteronism

ArticleYear
Phosphorylation by PKC and PKA regulate the kinase activity and downstream signaling of WNK4.
    Proceedings of the National Academy of Sciences of the United States of America, 2017, 01-31, Volume: 114, Issue:5

    Topics: Angiotensin II; Animals; Blood Volume; Chlorocebus aethiops; COS Cells; Cyclic AMP-Dependent Protein

2017